Our present study demonstrated that the level of α-synuclein could be downregulated by LETX-VI, which implies that LETX-VI is able to inhibit the abnormal accumulation of α-synuclein and thus impedes the formation of Lewy bodies, preventing or delaying the development of PD. The gene discussed is SNCA; the disease is Parkinson disease.